Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “Long‐term results of a phase 2 trial of nilotinib 400 mg twice daily in newly diagnosed patients with chronic‐phase chronic myeloid leukemia”.
Jörge E. Cortes, Keyur P. Patel, Susan O’Brien, Graciela M. Nogueras‐González, Marina Konopleva +11 more
Jörge E. Cortes, Keyur P. Patel, Lucia Masárová, Gautam Borthakur, Farhad Ravandi +14 more
Koji Sasaki, Jayastu Senapati, Shimin Hu, Sara Dellasala, Ghayas C. Issa +3 more
Elias Jabbour, Sara Dellasala, G. Issa, Tapan Kadia, J. Senapati +10 more